A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis
Status:
Completed
Trial end date:
2016-11-16
Target enrollment:
Participant gender:
Summary
An evaluation of the activity of cabazitaxel chemotherapy in relapsed cancer of the penis.
Safety and tolerability will be monitored and survival will be assessed. It is hypothesised
that cabazitaxel is useful in increasing progression free survival in relapsed penile cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospitals Bristol and Weston NHS Foundation Trust